Articles in section Research & Development
<< Opinion & Analysis | 447 articles | Royalties >> |
<< Previous | Pages 1 ..5 6 7 8 9 10 .. 45 | Next >> |
-
Merck Forms NASH Therapy Alliance with Aligos to Bolster Liver Disease Pipeline
-
Merck KGaA Strengthens Synthetic Lethality Pipeline with US$6.9 B Artios Alliance
-
Biogen Licenses Sage’s GABAA Modulators to Bolster CNS Pipeline
-
Merck Signs Two Oncology Collaborations with Seattle Genetics
-
Gilead Expands Deal and Triples Tango Targets to 15
-
Genentech Pays US$120 M Upfront for UCB’s Tau-targeting Antibody UCB0107
-
GlaxoSmithKline Partners with CureVac to Develop mRNA-based Vaccines
-
Sanofi Expands mRNA Collaboration with Translate Bio
-
GlaxoSmithKline Signs US$3 B Synthetic Lethality Alliance with IDEAYA Biosciences
-
AbbVie Commits US$750 M Upfront to Oncology Collaboration with Genmab